These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 17894307)

  • 1. Novel therapeutic aspects of percutaneous aortic valve replacement with the 21F CoreValve Revalving System.
    Berry C; Asgar A; Lamarche Y; Marcheix B; Couture P; Basmadjian A; Ducharme A; Laborde JC; Cartier R; Bonan R
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):610-6. PubMed ID: 17894307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve Revalving system.
    Grube E; Buellesfeld L; Mueller R; Sauren B; Zickmann B; Nair D; Beucher H; Felderhoff T; Iversen S; Gerckens U
    Circ Cardiovasc Interv; 2008 Dec; 1(3):167-75. PubMed ID: 20031675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome.
    Grube E; Schuler G; Buellesfeld L; Gerckens U; Linke A; Wenaweser P; Sauren B; Mohr FW; Walther T; Zickmann B; Iversen S; Felderhoff T; Cartier R; Bonan R
    J Am Coll Cardiol; 2007 Jul; 50(1):69-76. PubMed ID: 17601548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study.
    Grube E; Laborde JC; Gerckens U; Felderhoff T; Sauren B; Buellesfeld L; Mueller R; Menichelli M; Schmidt T; Zickmann B; Iversen S; Stone GW
    Circulation; 2006 Oct; 114(15):1616-24. PubMed ID: 17015786
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of percutaneous aortic valve replacement on coronary blood flow assessed with transesophageal Doppler echocardiography in patients with severe aortic stenosis.
    Ben-Dor I; Goldstein SA; Waksman R; Satler LF; Li Y; Syed AI; Maluenda G; Collins SD; Suddath WO; Torguson R; Xue Z; Kaneshige K; Okubagzi P; Wang Z; Kent KM; Pichard AD
    Am J Cardiol; 2009 Sep; 104(6):850-5. PubMed ID: 19733723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis.
    Tamburino C; Capodanno D; Mulè M; Scarabelli M; Cammalleri V; Barbanti M; Calafiore A; Ussia G
    J Invasive Cardiol; 2009 Mar; 21(3):93-8. PubMed ID: 19258637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcatheter aortic valve implantation: anesthetic considerations.
    Billings FT; Kodali SK; Shanewise JS
    Anesth Analg; 2009 May; 108(5):1453-62. PubMed ID: 19372319
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrograde transarterial implantation of a nonmetallic aortic valve prosthesis in high-surgical-risk patients with severe aortic stenosis: a first-in-man feasibility and safety study.
    Schofer J; Schlüter M; Treede H; Franzen OW; Tübler T; Pascotto A; Low RI; Bolling SF; Meinertz T; Reichenspurner H
    Circ Cardiovasc Interv; 2008 Oct; 1(2):126-33. PubMed ID: 20031667
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Six-month results of a repositionable and retrievable pericardial valve for transcatheter aortic valve replacement: the Direct Flow Medical aortic valve.
    Treede H; Tübler T; Reichenspurner H; Grube E; Pascotto A; Franzen O; Mueller R; Low R; Bolling SF; Meinertz T; Schofer J
    J Thorac Cardiovasc Surg; 2010 Oct; 140(4):897-903. PubMed ID: 20392455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical aspects of endovascular retrograde implantation of the aortic CoreValve bioprosthesis in high-risk older patients with severe symptomatic aortic stenosis.
    Marcheix B; Lamarche Y; Berry C; Asgar A; Laborde JC; Basmadjian A; Ducharme A; Denault A; Bonan R; Cartier R
    J Thorac Cardiovasc Surg; 2007 Nov; 134(5):1150-6. PubMed ID: 17976442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical profile, treatment assignment and clinical outcome of patients with severe aortic stenosis not eligible to participate in a clinical trial of percutaneous aortic valve replacement.
    Ben-Dor I; Pichard AD; Satler LF; Okubagzi P; Torguson R; Xue Z; Kaneshige K; Goldstein SA; Syed AI; Li Y; Lemesle G; Maluenda G; Collins SD; Wang Z; Suddath WO; Kent KM; Lindsay J; Waksman R
    Am J Cardiol; 2010 Mar; 105(6):857-61. PubMed ID: 20211332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fatal ischemic stroke related to nonpermissive peripheral artery access for percutaneous aortic valve replacement.
    Berry C; Cartier R; Bonan R
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):56-63. PubMed ID: 17154428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aortic valve replacement in isolated severe aortic stenosis with left ventricular dysfunction: long-term survival and ventricular recovery.
    Rabus MB; Kirali K; Kayalar N; Tuncer EY; Toker ME; Yakut C
    Anadolu Kardiyol Derg; 2009 Feb; 9(1):41-6. PubMed ID: 19196573
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Up to twenty-five-year survival after aortic valve replacement with size 19 mm valves.
    Rubio Alvarez J; Sierra Quiroga J; Vega Fernandez M; Adrio Nazar B; Gude Sampedro F; Martinez Comendador JM; Martinez Cereijo JM; Alves Perez MT
    Interact Cardiovasc Thorac Surg; 2010 Jan; 10(1):32-5. PubMed ID: 19770137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team.
    Bleiziffer S; Ruge H; Mazzitelli D; Schreiber C; Hutter A; Laborde JC; Bauernschmitt R; Lange R
    Eur J Cardiothorac Surg; 2009 Apr; 35(4):615-20; discussion 620-1. PubMed ID: 19233669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcome after valve replacement for severe aortic stenosis associated with reduced left ventricular ejection fraction.
    Maillet JM; Le Besnerais P; Benvenuti C; Noblesse E; Ruffenach A; Nataf P; Brodaty D
    J Heart Valve Dis; 2005 Nov; 14(6):760-5. PubMed ID: 16359056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience.
    Cribier A; Eltchaninoff H; Tron C; Bauer F; Agatiello C; Nercolini D; Tapiero S; Litzler PY; Bessou JP; Babaliaros V
    J Am Coll Cardiol; 2006 Mar; 47(6):1214-23. PubMed ID: 16545654
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-risk aortic valve replacement: are the outcomes as bad as predicted?
    Grossi EA; Schwartz CF; Yu PJ; Jorde UP; Crooke GA; Grau JB; Ribakove GH; Baumann FG; Ursumanno P; Culliford AT; Colvin SB; Galloway AC
    Ann Thorac Surg; 2008 Jan; 85(1):102-6; discussion 107. PubMed ID: 18154791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Coronary artery bypass grafting combined with aortic valve replacement in healthy octogenarians does not increase postoperative risk.
    Brunvand H; Offstad J; Nitter-Hauge S; Svennevig JL
    Scand Cardiovasc J; 2002 Sep; 36(5):297-301. PubMed ID: 12470398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is patient-prosthesis mismatch an independent risk factor for early and mid-term overall mortality in adult patients undergoing aortic valve replacement?
    Urso S; Sadaba R; Aldamiz-Echevarria G
    Interact Cardiovasc Thorac Surg; 2009 Sep; 9(3):510-8. PubMed ID: 19497953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.